Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT.
Onjukka E, Fiorino C, Cicchetti A, Palorini F, Improta I, Gagliardi G, Cozzarini C, Degli Esposti C, Gabriele P, Valdagni R, Rancati T. Onjukka E, et al. Among authors: palorini f. Acta Oncol. 2019 Dec;58(12):1757-1764. doi: 10.1080/0284186X.2019.1635267. Epub 2019 Jul 12. Acta Oncol. 2019. PMID: 31298076
Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Results of a cohort study.
Cozzarini C, Rancati T, Carillo V, Civardi F, Garibaldi E, Franco P, Avuzzi B, Esposti CD, Girelli G, Iotti C, Palorini F, Vavassori V, Valdagni R, Fiorino C. Cozzarini C, et al. Among authors: palorini f. Radiother Oncol. 2015 Aug;116(2):185-91. doi: 10.1016/j.radonc.2015.07.048. Epub 2015 Aug 11. Radiother Oncol. 2015. PMID: 26276529 Clinical Trial.
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy.
Palorini F, Rancati T, Cozzarini C, Improta I, Carillo V, Avuzzi B, Casanova Borca V, Botti A, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Iotti C, Maggio A, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Valdagni R, Fiorino C. Palorini F, et al. Radiother Oncol. 2016 Jan;118(1):92-8. doi: 10.1016/j.radonc.2015.11.036. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777123 Clinical Trial.
Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model.
Fiorino C, Broggi S, Fossati N, Cozzarini C, Goldner G, Wiegel T, Hinkelbein W, Karnes RJ, Boorjian SA, Haustermans K, Joniau S, Palorini F, Shariat S, Montorsi F, Van Poppel H, Di Muzio N, Calandrino R, Briganti A. Fiorino C, et al. Among authors: palorini f. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):333-340. doi: 10.1016/j.ijrobp.2016.06.014. Epub 2016 Jun 18. Int J Radiat Oncol Biol Phys. 2016. PMID: 27497691
Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: Results from a large pooled population.
Cicchetti A, Rancati T, Ebert M, Fiorino C, Palorini F, Kennedy A, Joseph DJ, Denham JW, Vavassori V, Fellin G, Avuzzi B, Stucchi C, Valdagni R. Cicchetti A, et al. Among authors: palorini f. Phys Med. 2016 Dec;32(12):1690-1697. doi: 10.1016/j.ejmp.2016.09.018. Epub 2016 Oct 6. Phys Med. 2016. PMID: 27720692 Free article. Clinical Trial.
Eleven-year management of prostate cancer patients on active surveillance: what have we learned?
Marenghi C, Alvisi MF, Palorini F, Avuzzi B, Badenchini F, Bedini N, Bellardita L, Biasoni D, Bosetti D, Casale A, Catanzaro M, Colecchia M, De Luca L, Donegani S, Dordoni P, Lanocita R, Maffezzini M, Magnani T, Menichetti J, Messina A, Morlino S, Paolini B, Rancati T, Stagni S, Tesone A, Torelli T, Tulli Baldoin E, Vaiani M, Villa S, Villa S, Zaffaroni N, Nicolai N, Salvioni R, Valdagni R. Marenghi C, et al. Among authors: palorini f. Tumori. 2017 Sep 18;103(5):464-474. doi: 10.5301/tj.5000649. Epub 2017 Jun 14. Tumori. 2017. PMID: 28623636 Free PMC article.
22 results